All Featured Insights

Turmoil in the nation’s public health agency leads to turmoil in vaccine policy, Medicare dips its toes into the prior-authorization waters.

UnitedHealth’s difficulties continue, more doctors exit traditional Medicare, troubling new report on hospital safety reporting

VP Harris proposes that Medicare cover home health aides, four health systems launch a new company, and CMS releases its initial list for $2 generic drugs.

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

Ozempic trial shows the drug slows kidney disease progression, a blood-based colorectal cancer test is endorsed for FDA approval, and nursing home trade groups sue over the new staffing mandate.

Telehealth company Hims & Hers unveils $199 weight-loss shots, CMS launches an emergency care complaint portal for patients, and the Senate Finance Committee signals interest in Medicare physician payment reforms.